Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 441

1.

Inhibition of histamine-mediated signaling confers significant protection against severe malaria in mouse models of disease.

Beghdadi W, Porcherie A, Schneider BS, Dubayle D, Peronet R, Huerre M, Watanabe T, Ohtsu H, Louis J, Mécheri S.

J Exp Med. 2008 Feb 18;205(2):395-408. doi: 10.1084/jem.20071548. Epub 2008 Jan 28.

2.

[Role of histamine and histamine receptors in the pathogenesis of malaria].

Beghdadi W, Porcherie A, Schneider BS, Dubayle D, Peronet R, Huerre M, Watanabe T, Ohtsu H, Louis J, Mécheri S.

Med Sci (Paris). 2009 Apr;25(4):377-81. doi: 10.1051/medsci/2009254377. Review. French.

3.

Histamine H(3) receptor-mediated signaling protects mice from cerebral malaria.

Beghdadi W, Porcherie A, Schneider BS, Morisset S, Dubayle D, Peronet R, Dy M, Louis J, Arrang JM, Mécheri S.

PLoS One. 2009 Jun 23;4(6):e6004. doi: 10.1371/journal.pone.0006004.

4.

Malaria-specific and nonspecific activation of CD8+ T cells during blood stage of Plasmodium berghei infection.

Miyakoda M, Kimura D, Yuda M, Chinzei Y, Shibata Y, Honma K, Yui K.

J Immunol. 2008 Jul 15;181(2):1420-8.

5.

Pathological role of Toll-like receptor signaling in cerebral malaria.

Coban C, Ishii KJ, Uematsu S, Arisue N, Sato S, Yamamoto M, Kawai T, Takeuchi O, Hisaeda H, Horii T, Akira S.

Int Immunol. 2007 Jan;19(1):67-79. Epub 2006 Nov 29.

6.

Cutting edge: selective blockade of LIGHT-lymphotoxin beta receptor signaling protects mice from experimental cerebral malaria caused by Plasmodium berghei ANKA.

Randall LM, Amante FH, Zhou Y, Stanley AC, Haque A, Rivera F, Pfeffer K, Scheu S, Hill GR, Tamada K, Engwerda CR.

J Immunol. 2008 Dec 1;181(11):7458-62.

7.

Perforin-dependent brain-infiltrating cytotoxic CD8+ T lymphocytes mediate experimental cerebral malaria pathogenesis.

Nitcheu J, Bonduelle O, Combadiere C, Tefit M, Seilhean D, Mazier D, Combadiere B.

J Immunol. 2003 Feb 15;170(4):2221-8.

8.

Perforin mediated apoptosis of cerebral microvascular endothelial cells during experimental cerebral malaria.

Potter S, Chan-Ling T, Ball HJ, Mansour H, Mitchell A, Maluish L, Hunt NH.

Int J Parasitol. 2006 Apr;36(4):485-96. Epub 2006 Jan 19.

PMID:
16500656
9.

Depletion of CD4+ or CD8+ T-cells prevents Plasmodium berghei induced cerebral malaria in end-stage disease.

Hermsen C, van de Wiel T, Mommers E, Sauerwein R, Eling W.

Parasitology. 1997 Jan;114 ( Pt 1):7-12.

PMID:
9011069
10.

Filaria-induced IL-10 suppresses murine cerebral malaria.

Specht S, Ruiz DF, Dubben B, Deininger S, Hoerauf A.

Microbes Infect. 2010 Aug;12(8-9):635-42. doi: 10.1016/j.micinf.2010.04.006. Epub 2010 Apr 24.

PMID:
20420933
11.

Chemokine receptor CXCR3 and its ligands CXCL9 and CXCL10 are required for the development of murine cerebral malaria.

Campanella GS, Tager AM, El Khoury JK, Thomas SY, Abrazinski TA, Manice LA, Colvin RA, Luster AD.

Proc Natl Acad Sci U S A. 2008 Mar 25;105(12):4814-9. doi: 10.1073/pnas.0801544105. Epub 2008 Mar 17.

12.

Systemic lack of canonical histamine receptor signaling results in increased resistance to autoimmune encephalomyelitis.

Saligrama N, Case LK, del Rio R, Noubade R, Teuscher C.

J Immunol. 2013 Jul 15;191(2):614-22. doi: 10.4049/jimmunol.1203137. Epub 2013 Jun 14.

13.

Coincident parasite and CD8 T cell sequestration is required for development of experimental cerebral malaria.

McQuillan JA, Mitchell AJ, Ho YF, Combes V, Ball HJ, Golenser J, Grau GE, Hunt NH.

Int J Parasitol. 2011 Feb;41(2):155-63. doi: 10.1016/j.ijpara.2010.08.003. Epub 2010 Sep 7.

PMID:
20828575
14.

IP-10-mediated T cell homing promotes cerebral inflammation over splenic immunity to malaria infection.

Nie CQ, Bernard NJ, Norman MU, Amante FH, Lundie RJ, Crabb BS, Heath WR, Engwerda CR, Hickey MJ, Schofield L, Hansen DS.

PLoS Pathog. 2009 Apr;5(4):e1000369. doi: 10.1371/journal.ppat.1000369. Epub 2009 Apr 3.

15.

The transcription factor T-bet regulates parasitemia and promotes pathogenesis during Plasmodium berghei ANKA murine malaria.

Oakley MS, Sahu BR, Lotspeich-Cole L, Solanki NR, Majam V, Pham PT, Banerjee R, Kozakai Y, Derrick SC, Kumar S, Morris SL.

J Immunol. 2013 Nov 1;191(9):4699-708. doi: 10.4049/jimmunol.1300396. Epub 2013 Sep 27.

16.

IL-10 plays a crucial role for the protection of experimental cerebral malaria by co-infection with non-lethal malaria parasites.

Niikura M, Kamiya S, Nakane A, Kita K, Kobayashi F.

Int J Parasitol. 2010 Jan;40(1):101-8. doi: 10.1016/j.ijpara.2009.08.009. Epub 2009 Sep 6.

PMID:
19735663
17.

Pathogenic T cells in cerebral malaria.

Rénia L, Potter SM, Mauduit M, Rosa DS, Kayibanda M, Deschemin JC, Snounou G, Grüner AC.

Int J Parasitol. 2006 May 1;36(5):547-54. Epub 2006 Mar 10. Review.

PMID:
16600241
18.

T cell response in malaria pathogenesis: selective increase in T cells carrying the TCR V(beta)8 during experimental cerebral malaria.

Boubou MI, Collette A, Voegtlé D, Mazier D, Cazenave PA, Pied S.

Int Immunol. 1999 Sep;11(9):1553-62.

20.

Cerebral malaria: role of microparticles and platelets in alterations of the blood-brain barrier.

Combes V, Coltel N, Faille D, Wassmer SC, Grau GE.

Int J Parasitol. 2006 May 1;36(5):541-6. Epub 2006 Mar 10. Review.

PMID:
16600245
Items per page

Supplemental Content

Write to the Help Desk